RBC Capital reiterates LyondellBasell stock rating on Q1 beat

LyondellBasell beat Q1 EBITDA expectations at $615 million versus RBC’s $600 million estimate and consensus at $553 million, while adjusted EPS of $0.49 also topped the $0.24 consensus. Revenue came in light at $7.2 billion, down 6% year over year from $7.7 billion, but RBC reiterated Outperform and a $91 target, citing improving polyolefin margins and potential 2026 EBITDA approaching $5 billion. The company also completed European asset sales and still faces feedstock and demand pressures tied to Asia disruptions and Middle East conflict.

Analysis

LYB is starting to look less like a pure cyclical and more like an option on regional supply rationalization plus geopolitically induced tightness in polyolefins. The key second-order effect is that North American and European asset concentration becomes an advantage precisely as Asian feedstock volatility and capacity discipline raise the marginal cost curve elsewhere; that can sustain a price umbrella even if end-demand remains merely mediocre. In other words, the market may be underestimating how much of the margin recovery can come from supply-side repair rather than a full demand rebound.

The bigger setup is timing: the P&L inflection appears more likely over the next 2-4 quarters than immediately, because the catalyst is not a one-quarter beat but a sustained re-rating of 2026 earnings power. If the market starts to believe EBITDA can migrate toward the higher end of current estimates, LYB should trade more like a cash-generation story with balance-sheet optionality than a low-multiple chemical name. That said, the stock has already moved a lot, so the easy money on sentiment may be behind us unless polyethylene prices continue to inflect and downstream buyers absorb the move without cutting volumes.

The contrarian miss is that consensus may be anchoring on revenue weakness as a demand signal when the more relevant variable is margin duration. If affordability pressure in housing worsens, LYB could see volume pressure, but pricing power in constrained chains can offset that faster than the street expects. The real risk is a lagged demand break: if macro weakness finally hits construction and industrial end markets into late summer, the margin story can reverse quickly even with tight supply, because the market will de-rate forward earnings before the actual tonnage shows up.

Key Decisions for Investors

• Go long LYB on pullbacks, with a 3-6 month horizon: the trade is on margin normalization and rerating toward 2026 earnings, but size modestly because the stock has already re-rated sharply; risk/reward improves if it retraces 8-12% from current levels.
• Pair trade: long LYB / short a more Asia-exposed chemical name or diversified cyclical with weaker pricing leverage, to isolate the benefit of Western capacity concentration and supply rationalization over the next 2-4 quarters.
• Buy LYB call spreads for the next 6-9 months rather than outright equity if implied vol is reasonable: upside comes from a further multiple expansion on sustained polyolefin tightness, while downside is capped if end-demand rolls over.
• Trim or avoid chasing here if your mandate is valuation-sensitive cyclicals; wait for evidence that EBITDA revisions are being reset higher over the next earnings cycle before adding aggressively.
• Set a risk trigger on signs of demand destruction in housing/industrial channels over the next 60-90 days; if order rates weaken while pricing holds, reduce exposure because the market will likely de-rate faster than fundamentals can stabilize.